Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ASND

175.39999 USD
0.65
0.37%
Last update Jul 16, 3:59 PM EDT
Market closed
Day range
171.10001
176.23000
Previous close
174.75
Open
175
Access this stock data via API
Subscribe
Ascendis Pharma A/S
175.40
0.65
0.37%

Overview

Description

Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to create therapeutic products that improve efficacy and therapeutic outcomes. Ascendis Pharma primarily targets endocrinology, aiming to treat conditions such as growth hormone deficiencies and hypoparathyroidism. The company's commitment to integrating advanced biotechnology through TransCon allows for sustained release and limited side effects, offering efficient and effective treatment options. Headquartered in Denmark, Ascendis Pharma plays a significant role in the biotech sector, driving innovation with a strong emphasis on developmental pipeline and collaborations designed to address complex diseases. With its growing presence and dedicated R&D initiatives, Ascendis continues to make critical contributions to the healthcare industry by delivering promising new therapies for rare conditions.

About

CEO
Mr. Jan Moller Mikkelsen
Employees
1017
Address
Tuborg Boulevard 12
Hellerup, 2900
Phone
45 70 22 22 44
Instrument type
Depositary receipt
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 15 minutes

01:44
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).